Advertisement
Australia markets close in 4 hours 49 minutes
  • ALL ORDS

    7,826.00
    -72.90 (-0.92%)
     
  • ASX 200

    7,568.70
    -73.40 (-0.96%)
     
  • AUD/USD

    0.6394
    -0.0031 (-0.49%)
     
  • OIL

    84.41
    +1.68 (+2.03%)
     
  • GOLD

    2,406.40
    +8.40 (+0.35%)
     
  • Bitcoin AUD

    97,070.30
    +883.61 (+0.92%)
     
  • CMC Crypto 200

    1,294.82
    +409.28 (+46.21%)
     
  • AUD/EUR

    0.6013
    -0.0018 (-0.29%)
     
  • AUD/NZD

    1.0874
    -0.0001 (-0.01%)
     
  • NZX 50

    11,821.67
    -14.37 (-0.12%)
     
  • NASDAQ

    17,394.31
    -99.31 (-0.57%)
     
  • FTSE

    7,877.05
    +29.06 (+0.37%)
     
  • Dow Jones

    37,775.38
    +22.07 (+0.06%)
     
  • DAX

    17,837.40
    +67.38 (+0.38%)
     
  • Hang Seng

    16,385.87
    0.00 (0.00%)
     
  • NIKKEI 225

    37,253.59
    -826.11 (-2.17%)
     

Why Ocugen, Sorrento Therapeutics, and VBI Vaccines Are on the Move Today

Why Ocugen, Sorrento Therapeutics, and VBI Vaccines Are on the Move Today

The back half of 2022 is already shaping up to be a stock picker's market. Today's mixed trading session in the volatile healthcare sector is a case in point. For example, shares of the clinical-stage biotech Ocugen (NASDAQ: OCGN) were down by a hefty 9.5% and Sorrento Therapeutics' (NASDAQ: SRNE) equity was in the red by 5.62% at 11:02 a.m. ET Thursday.